Chemical Structure : Soquelitinib
CAS No.: 2226636-04-8
货号: PC-26224Not For Human Use, Lab Use Only.
Soquelitinib (CPI-818) is a selective, covalent, orally bioavailable inhibitor of ITK kinase (Interleukin-2-inducible T cell kinase) with Kd of 6.5 nM, >80-fold selective over other TEC kinase family members, binds covalently to cysteine 442 of ITK and blocks its function.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥2180 | In stock | |
| 10 mg | ¥3480 | In stock | |
| 25 mg | ¥5480 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Soquelitinib (CPI-818) is a selective, covalent, orally bioavailable inhibitor of ITK kinase (Interleukin-2-inducible T cell kinase) with Kd of 6.5 nM, >80-fold selective over other TEC kinase family members, binds covalently to cysteine 442 of ITK and blocks its function.
Soquelitinib displays >100-fold selectivity compared to binding to resting lymphocyte kinase (RLK).
Soquelitinib inhibits TCR signaling downstream of ITK and blocks IL-2 production, suppresses IL-2 secretion in Jurkat cells in response to TCR stimulation with a mean IC50 of 136 nM.
Soquelitinib suppresses Th2 associated cytokines and induces Th1 skewing in CD4 T cells.
Soquelitinib inhibits tumor growth and enhances cytolytic capacity of tumor infiltrating T cells.
Soquelitinib enhances anti-PD1 and anti-CTLA4 efficacy in the CT26 tumor model.
Soquelitinib inhibits T cell exhaustion process in vitro.
| 分子量 | 514.66 | |
| 分子式 | C25H30N4O4S2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
(R)-N-(5-((5-(4-Acryloyl-3-methyl-1,4-diazepane-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)cyclopropanecarboxamide |
|
1. Hsu L Y, et al. bioRxiv, 2023: 2023.10. 27.564296.
2. Hsu L Y, et al. bioRxiv, 2023: 2023.07. 05.547822.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright